Searching
Searching providers and clinics...
Clerava is checking public healthcare sources and community clinic listings for the best nearby matches.
Please wait while results load.
Searching
Clerava is checking public healthcare sources and community clinic listings for the best nearby matches.
Search results
Review nearby providers, community clinics, and lower-cost care options, then narrow down by the kind of care you need.
Results are drawn from public healthcare sources and clinic listings. They are here to help you navigate options, not replace medical advice.
Smart search interpretation
Clerava is treating this as a general care search and will show provider and clinic matches.
Medication safety
View detailsMekinist
Generic: TRAMETINIB
When to use: 1 INDICATIONS AND USAGE MEKINIST is a kinase inhibitor indicated as a single agent for the treatment of BRAF-inhibitor treatment-naïve patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test. ( 1.1 , 2.1 ) MEKINIST is indicated, in combination with dabrafenib, for: the treatment of patients with unresectable or metastatic melanoma…
Dosage: 2 DOSAGE AND ADMINISTRATION The recommended dosage of MEKINIST in adult patients is 2 mg orally once daily. The recommended dosage for MEKINIST in pediatric patients is based on body weight. ( 2 ) 2.1 Patient Selection Melanoma Confirm the presence of BRAF V600E or V600K mutation in tumor specimens prior to initiation of treatment with MEKINIST as a single agent or in combination with dabrafenib…
Drug information is from openFDA and is for educational purposes. It does not replace medical advice.
Showing 0 of 0 results for "Mekinist"
Sorted by Best match. Best match prioritizes providers, verified records, and closer local matches when available.
No provider matches
The medication safety information above was found, but no providers matched your query. Try searching for a provider name or condition instead.